tirzepatide lizard venom We wouldn't have Ozempic without Gila monsters — their hunger-regulating inspired weight-loss drugs Ozempic: How gila monster venom

Major change: the ADA no longer recommends A1C to guide therapy selection

Discover how leading R&D teams use Cypris Q to monitor technology landscapes and identify opportunities faster - Book a demo Executive Summary GLP-1based obesity pharmacotherapy has evolved from single-hormone appetite suppression into a platform competition spanning poly-agonist biology, delivery convenience, and body-composition optimization

IGF-1 replacement therapy induced a restoration of the altered GH/IGF-1 axis by reducing circulating GH levels and recovering the somatostatinergic tone [292]

recent data show that children with obesity have a 46% prevalence of OSA when compared with children seen in a general pediatric clinic (33%)

Multiple taste receptors add to our perception of taste

Glucagon-like peptide-1 receptor activation does not affect re-endothelialization but reduces intimal hyperplasia via direct effects on smooth muscle cells in a nondiabetic model of arterial injury